相关实验视频
Updated: Jul 5, 2025

11:51
Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
11.9K
作为具有抗癌活性的小分子的新诺基诺林衍生物的有效合成
Gheorghita Zbancioc1, Ionel I Mangalagiu1,2, Costel Moldoveanu1
1Chemistry Department, Alexandru Ioan Cuza University of Iasi, 11 Carol 1st Bvd, 700506 Iasi, Romania.
Pharmaceuticals (Basel, Switzerland)
|January 23, 2024
概括
新的诺基诺林衍生物被合成并测试了抗癌活性. 循环载荷管道显示出比四级盐更高的疗效,其中化合物5a在多个细胞系中是最有效的.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 诺基诺林衍生物正在探索潜在的治疗应用.
- 为新型异环化合物开发高效的合成路径至关重要.
研究的目的:
- 为了合成新的[c]类衍生物.
- 为了研究它们的体外抗癌活性.
- 为了比较不同的合成方法.
主要方法:
- 通过四极化和 [3+2] 双极循环加法进行合成.
- 使用微波 (MW) 和超声波 (US) 辐射相对于传统热加热 (TH) 的合成优化.
- 使用FTIR,HRMS和NMR光谱学进行结构性表征.
- 在各种细胞系上进行体外抗癌疗效测试.
主要成果:
- 与TH相比,MW和US辐射显著减少了反应时间,溶剂使用量和能源消耗.
- 所有合成的[c]衍生物 (四级盐和循环载荷管) 都被描述.
- 循环载荷管 (5a-c, 6a-c) 与四级盐 (3a-c) 相比,显示出更高的抗癌活性.
- 化合物5a表现出广泛的抗癌活性,而6c对SR白血病细胞系表现出显著的致命性.
结论:
- 使用MW和US辐射,可以实现诺基诺林衍生物的高效和绿色合成.
- 合成的循环载荷管道代表了有前途的抗癌药物.
- 结构-活性关系 (SAR) 分析为进一步的药物开发提供了见解.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
292
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
292
Diazonium Group Substitution with Halogens and Cyanide: Sandmeyer and Schiemann Reactions
1.9K
Arenediazonium substitution reactions occur when the diazonium group is substituted by various functional groups such as halides, hydroxyl, nitrile, etc. For instance, arenediazonium salts react with copper(I) salts of chloride, bromide, or cyanide to form corresponding aryl chlorides, bromides, and nitriles. These reactions are named Sandmeyer reactions. Although the mechanism of this reaction is complicated, as illustrated in Figure 1, they are believed to progress via an aryl copper...
1.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Nucleophilic Aromatic Substitution: Elimination–Addition
4.0K
Simple aryl halides do not react with nucleophiles. However, nucleophilic aromatic substitutions can be forced under certain conditions, such as high temperatures or strong bases. The mechanism of substitution under such conditions involves the highly unstable and reactive benzyne intermediate. Benzyne contains equivalent carbon centers at both ends of the triple bond, each of which is equally susceptible to nucleophilic attack. This 50–50 distribution of products is...
4.0K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K

